Navigation Links
EPA announces research strategy to study nanomaterials
Date:9/29/2009

WASHINGTON The U.S. Environmental Protection Agency today outlined a new research strategy to better understand how manufactured nanomaterials may harm human health and the environment. Nanomaterials are materials that are between approximately one and 100 nanometers. A nanometer is approximately 1/100,000 the width of a human hair. These materials are currently used in hundreds of consumer products, including sunscreen, cosmetics and sports equipment.

The strategy outlines what research EPA will support over the next several years to generate information about the safe use of nanotechnology and products that contain nano-scale materials. The strategy also includes research into ways nanotechnology can be used to clean up toxic chemicals in the environment.

Nanomaterials are used in a wide variety of consumer products. For instance, because of the unusual light-absorbing properties of the zinc or titanium nanoparticles they contain, high-SPF nano sunscreens are clear rather than white. Studies show that they provide superior protection against UV radiation.

EPA's role among federal agencies is to determine the potential hazards of nanotechnology and develop approaches to reduce or minimize any risks identified. As part of the strategy, researchers are investigating widely used nanomaterials, such as carbon nanotubes, which are used in vehicles, sports equipment and electronics; and titanium dioxide, which is used in paints, cosmetics and sunscreens.

The research is being conducted in EPA's own laboratories and by grant recipients as part of a collaborative effort with other federal organizations and the international community.

EPA's research is conducted using a multidisciplinary approach that examines all aspects of nanomaterials in the environment, from their manufacture and use to their disposal or recycling. EPA's new nanotechnology Web site provides more details about the research and offers news and publications.


'/>"/>

Contact: Dale Kemery
kemery.dale@epa.gov
202-564-7839
U.S. Environmental Protection Agency
Source:Eurekalert

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Reovirus and Cisplatin Research Supports U.S. Phase 2 Metastatic Melanoma Trial
2. MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
3. Axial Biotech Announces Commercial Availability of SCOLISCORE(TM) AIS Prognostic Test
4. Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock
5. Spherix Incorporated Announces Annual Shareholders Meeting Date
6. Compendia Bioscience Announces the Release of Oncomine 4 Research Edition
7. InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
8. MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
9. XRC Medical Imaging Announces Rapid Test Results
10. Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
11. Boston Scientific Announces Release of Next-Generation iLab(R) System Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... Austin, TX (PRWEB) , ... October 11, 2017 ... ... in August compared the implantation and pregnancy rates in frozen and fresh ... the contribution of progesterone and maternal age to IVF success. , After comparing ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):